Lumixyl MD Topical Brightening Creme

Lumixyl is a skin brightening/lightening peptide that does not irritate the skin like Kligmans Formula, Tretinoin, or Hydroquinone, and is not cytotoxic. It has been shown to be 5.5 times more effective than hydroquinone in preliminary trials.
Contains Lumixyl peptide, a lightening agent exclusive to this product.
Target unwanted discoloration with this patent pending creme formula. This revolutionary Lumixyl peptide works to brighten skin tone and increase luminosity without the use of hydroquinone. Lumixyl is a peptide technology that improves the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone.

Developed by dermatological researchers out of Stanford University, this ground-breaking technology is the only peptide capable of directly inhibiting the enzyme (tyrosinase) responsible for initiating the overproduction of melanin that can cause uneven pigmentation and dark spots.

Clinical studies demonstrate that topical use of Lumixyl visibly improves mild to moderate hyperpigmentation with excellent volunteer satisfaction in as little as 8 weeks.

Moreover, in-use and Repeated Insult Patch Testing (RIPT) studies confirm that Lumixyl is safe for topical use and does not elicit irritation or allergic reaction. Neither does Lumixyl cause increased sensitivity to sunlight as do many commonly used brightening agents. Lumixyl Topical Brightening Creme can be used alone or in combination with other treatments or devices such as tretinoin, laser resurfacing and SilkPeel Dermalinfusion, respectively, to diminish dark spots, uneven pigmentation and improve overall skin tone.

Directions: Start with clean, dry skin. Apply to skin at night, avoiding the delicate eye area. It is imperative to use a sunscreen of at least SPF 15 when using this product. Failure to do so can result in hyperpigmentation.
Lumixyl MD Topical Brightening Creme
Price:     $85.95